Download Files:
Cadisegliatin
$300 – $2,250
Products Details
Product Description
– Cadisegliatin (TTP-399) is a potential, orally active liver-selective glucokinase (GK) activator. Cadisegliatin has antihyperglycaemic activity. Cadisegliatin can be used for the research of type 2 diabetes[1][2].
Web ID
– HY-147254
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– Metabolism-sugar/lipid metabolism
Molecular Formula
– C21H33N3O4S2
References
– [1]Adrian Vella, et al. Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator. Sci Transl Med. 2019 Jan 16;11(475):eaau3441.|[2]International Nonproprietary Names for Pharmaceutical Substances (INN)
CAS Number
– 859525-02-3
Molecular Weight
– 455.63
Compound Purity
– 99.10
SMILES
– OC(CSC1=CN=C(S1)NC(N(C2CCCCC2)[C@H]3CC[C@@H](CC3)OCCC)=O)=O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– DMSO : 125 mg/mL (ultrasonic)
Target
– Glucokinase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
